Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
ACS Environ Au ; 3(6): 348-360, 2023 Nov 15.
Article in English | MEDLINE | ID: mdl-38028744

ABSTRACT

It is well known that atmospheric aerosol size and composition impact air quality, climate, and health. The aerosol composition is typically a mixture and consists of a wide range of organic and inorganic particles that interact with each other. Furthermore, water vapor is ubiquitous in the atmosphere, in indoor air, and within the human body's respiratory system, and the presence of water can alter the aerosol morphology and propensity to form droplets. Specifically, aerosol mixtures can undergo liquid-liquid phase separation (LLPS) in the presence of water vapor. However, the experimental conditions for which LLPS impacts water uptake and the subsequent prediction of aerosol mixtures are poorly understood. To improve our understanding of aerosol mixtures and droplets, this study explores two ternary systems that undergo LLPS, namely, the 2MGA system (sucrose + ammonium sulfate + 2-methylglutaric acid) and the PEG1000 system (sucrose + ammonium sulfate + polyethylene glycol 1000). In this study, the ratio of species and the O:C ratios are systematically changed, and the hygroscopic properties of the resultant aerosol were investigated. Here, we show that the droplet activation above 100% RH of the 2MGA system was influenced by LLPS, while the droplet activation of the PEG1000 system was observed to be linearly additive regardless of chemical composition, O:C ratio, and LLPS. A theoretical model that accounts for LLPS with O:C ratios was developed and predicts the water uptake of internally mixed systems of different compositions and phase states. Hence, this study provides a computationally efficient algorithm to account for the LLPS and solubility parameterized by the O:C ratio for droplet activation at supersaturated relative humidity conditions and may thus be extended to mixed inorganic-organic aerosol populations with unspeciated organic composition found in the ambient environment.

2.
Am J Cardiol ; 177: 61-68, 2022 08 15.
Article in English | MEDLINE | ID: mdl-35697544

ABSTRACT

The impact of substance abuse, including alcohol abuse or illicit drug use, on outcomes after left ventricular assist device (LVAD) implantation, has not been fully elucidated. Accordingly, to test the hypothesis that such a history would be associated with worse outcomes, we analyzed the Interagency Registry for Mechanically Assisted Circulatory Support registry. All patients from the Interagency Registry for Mechanically Assisted Circulatory Support registry who received a continuous-flow LVAD from June 2006 to December 2017 were included. The median follow-up duration was 12.9 months (interquartile range, 5.3 to 17.5). The final study group consisted of 15,069 patients, of which 1,184 (7.9%) had a history of alcohol abuse and 1,139 (7.6%) had a history of illicit drug use. The overall mortality rates in the alcohol, illicit drug, and control groups were 25%, 21%, and 29%, respectively. Cox regression analysis showed that having a history of alcohol abuse (hazard ratio, 0.97, 95% confidence interval, 0.84 to 1.13, p = 0.72) or illicit drug use (hazard ratio, 1.02, 95% confidence interval, 0.86 to 1.21, p = 0.81) was not significantly associated with increased risk of all-cause mortality when compared with general LVAD population. On the contrary, after adjusting for other covariates, a history of alcohol abuse or illicit drug use was significantly associated with increased device malfunction/pump thrombosis, device-related infection, or all-cause hospitalization (all p <0.05). Furthermore, After LVAD implantation, these patients had a lower quality of life assessed by the Kansas City Cardiomyopathy Questionnaire compared with those who did not. In conclusion, our findings suggest that patients with a history of alcohol abuse or illicit drug use are at risk for adverse device-related events with a lower quality of life after continuous-flow LVAD implantation compared with the general LVAD population.


Subject(s)
Alcoholism , Heart Failure , Heart-Assist Devices , Illicit Drugs , Alcoholism/complications , Alcoholism/epidemiology , Heart Failure/epidemiology , Heart Failure/etiology , Heart Failure/therapy , Heart-Assist Devices/adverse effects , Humans , Quality of Life , Registries , Retrospective Studies , Treatment Outcome
3.
Am J Transplant ; 18(12): 3021-3028, 2018 12.
Article in English | MEDLINE | ID: mdl-29607624

ABSTRACT

We performed a retrospective review of 402 consecutive patients who underwent heart transplantation at our institution between January 2009 and March 2017. A retained cardiovascular implantable electronic device (CIED) fragment was identified after transplantation in 49 of the 301 patients (16.2%) with CIED at baseline. Patients with retained fragments had leads with longer dwell times (median 2596 [1982, 3389] vs 1384 [610, 2202] days, P < .001), higher prevalence of previously abandoned leads (14.3% vs 2.8%, P = .003), and dual-coil defibrillator leads (98% vs 81%, P = .001) compared with patients without retained fragments. Five patients (10%) with retained CIED fragments underwent magnetic resonance imaging without adverse events. There was no difference in overall mortality between patients with and without CIED fragments (12% vs 11%, P = .81) Patients with retained fragments located in the superior vena cava had significantly higher fluoroscopic times (3.3 vs 2.9 minutes, P = .024) during subsequent endomyocardial biopsies. In a competing risk analysis, presence of a retained CIED fragment was associated with upper extremity deep venous thrombosis (sub hazard ratio [HR] 2.19, 95% confidence interval [CI] 1.17-4.10, P = .014) but not bloodstream infection after adjusting for potential confounders. In summary, retained CIED fragments are common after heart transplantation, and are associated with longer radiation exposure during biopsy procedures and upper extremity deep venous thrombosis.


Subject(s)
Defibrillators, Implantable/adverse effects , Device Removal/adverse effects , Foreign Bodies/complications , Graft Rejection/etiology , Heart Diseases/surgery , Heart Transplantation/adverse effects , Radiation Exposure/adverse effects , Female , Follow-Up Studies , Graft Survival , Humans , Male , Middle Aged , Postoperative Complications , Prognosis , Retrospective Studies , Risk Factors
4.
Ann Am Thorac Soc ; 11(10): 1623-32, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25406836

ABSTRACT

Proper and early identification of patients who harbor serious occult illness is the first step in developing a disease-management strategy. Identification of illnesses through the use of noninvasive techniques provides assurance of patient safety and is ideal. PA dilation is easily measured noninvasively and is due to a variety of conditions, including pulmonary hypertension (PH). The clinician should be able to thoroughly assess the significance of PA dilation in each individual patient. This involves knowledge of the ability of PA dilation to accurately predict PH, understand the wide differential diagnosis of causes of PA dilation, and reverse its life-threatening complications. We found that although PA dilation is suggestive of PH, data remain inconclusive regarding its ability to accurately predict PH. At this point, data are insufficient to place PA dilation into a PH risk-score equation. Here we review the causes and complications of PA dilation, define normal and abnormal PA measurements, and summarize the data linking its association to PH, while suggesting an algorithm designed to assist clinicians in patient work-up after recognizing PA dilation.


Subject(s)
Diagnostic Imaging/methods , Hypertension, Pulmonary/diagnosis , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/pathology , Cardiac Catheterization , Dilatation, Pathologic/diagnosis , Humans , Magnetic Resonance Angiography , Reproducibility of Results , Tomography, X-Ray Computed
5.
J Air Waste Manag Assoc ; 63(11): 1264-9, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24344570

ABSTRACT

The formation of aerosols is a key component in understanding cloud formation in the context of radiative forcings and global climate modeling. Biogenic volatile organic compounds (BVOCs) are a significant source of aerosols, yet there is still much to be learned about their structures, sources, and interactions. The aims of this project were to identify the BVOCs found in the defense chemicals of the brown marmorated stink bug Halymorpha halys and quantify them using gas chromatography-mass spectrometry (GC/MS) and test whether oxidation of these compounds by ozone-promoted aerosol and cloud seed formation. The bugs were tested under two conditions: agitation by asphyxiation and direct glandular exposure. Tridecane, 2(5H)-furanone 5-ethyl, and (E)-2-decenal were identified as the three most abundant compounds. H. halys were also tested in the agitated condition in a smog chamber. It was found that in the presence of 100-180 ppm ozone, secondary aerosols do form. A scanning mobility particle sizer (SMPS) and a cloud condensation nuclei counter (CCNC) were used to characterize the secondary aerosols that formed. This reaction resulted in 0.23 microg/ bug of particulate mass. It was also found that these secondary organic aerosol particles could act as cloud condensation nuclei. At a supersaturation of 1%, we found a kappa value of 0.09. Once regional populations of these stink bugs stablilize and the populations estimates can be made, the additional impacts of their contribution to regional air quality can be calculated.


Subject(s)
Heteroptera/chemistry , Volatile Organic Compounds/chemistry , Aerosols , Animals , Heteroptera/physiology
6.
Future Cardiol ; 9(3): 387-403, 2013 May.
Article in English | MEDLINE | ID: mdl-23668743

ABSTRACT

Diabetes mellitus is a metabolic disease with microvascular and macrovascular complications, and is well known to increase the risk of coronary atherosclerosis. Despite recent reductions in the prevalence of coronary artery disease and cardiovascular events in the USA, persons with diabetes remain up to four-times as likely to die of cardiovascular disease than the general population. Diabetes is associated with an atherogenic lipid profile, induces a hypercoagulable state, and increases coronary plaque volume, progression and instability. Medicinal and procedural treatments in the patient with diabetes should be multifactorial, targeting and managing the many coexisting risk factors that contribute to atherosclerosis. This type of treatment is complex and should be individualized, and guided by a careful review of recent literature. Here we discuss important clinical data and their impact on up-to-date recommendations for the management of coronary artery disease in the patient with Type 2 diabetes mellitus.


Subject(s)
Coronary Artery Disease/complications , Coronary Artery Disease/therapy , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/therapy , Coronary Artery Disease/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Humans , Insulin Resistance
SELECTION OF CITATIONS
SEARCH DETAIL
...